Segment Information (Tables)

6 Months Ended

Jun. 30, 2020

Segment Information

Summary of results of operations by segment

			Contract		Corporate		Total
Three Months Ended June 30, 2020	Therapeutics		Research		and Other		Company
Total revenue	$	193	$	3,657	$	(1,804)	$	2,046
Cost of revenue		—		3,082		(1,693)		1,389
Research and development		6,577		—		(111)		6,466
General and administrative		—		688		4,884		5,572
Loss from operations	$	(6,384)	$	(113)	$	(4,884)	$	(11,381)
Loss from discontinued operations	$	(27)	$	—	$	—	$	(27)
			Contract		Corporate		Total
Three Months Ended June 30, 2019	Therapeutics		Research		and Other		Company
Total revenue	$	—	$	3,807	$	(2,921)	$	886
Cost of revenue		—		3,819		(2,825)		994
Research and development		17,615		—		(96)		17,519
General and administrative		359		613		6,497		7,469
Goodwill impairment		18,504		—		—		18,504
Loss from operations	$	(36,478)	$	(625)	$	(6,497)	$	(43,600)
Loss from discontinued operations	$	(5,298)	$	—	$	(893)	$	(6,191)
			Contract		Corporate		Total
Six Months Ended June 30, 2020	Therapeutics		Research		and Other		Company
Total revenue	$	411	$	7,064	$	(4,022)	$	3,453
Cost of revenue		—		6,468		(3,810)		2,658
Research and development		16,121		—		(212)		15,909
General and administrative		—		1,440		10,333		11,773
Loss from operations	$	(15,710)	$	(844)	$	(10,333)	$	(26,887)
Loss from discontinued operations	$	(284)	$	—	$	(1)	$	(285)
			Contract		Corporate		Total
Six Months Ended June 30, 2019	Therapeutics		Research		and Other		Company
Total revenue	$	—	$	8,995	$	(6,846)	$	2,149
Cost of revenue		—		8,856		(6,655)		2,201
Research and development		37,352		—		(191)		37,161
General and administrative		477		1,145		13,304		14,926
Goodwill impairment		18,504		—		—		18,504
Loss from operations	$	(56,333)	$	(1,006)	$	(13,304)	$	(70,643)
Loss from discontinued operations	$	(14,720)	$	—	$	(1,763)	$	(16,483)